Patents by Inventor Shefali BHUMBRA

Shefali BHUMBRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TCR delta variable 1 antibodies
    Patent number: 12703746
    Abstract: The present invention provides high-affinity anti-TCR delta variable 1 (anti-V?1) antibodies and antibody fragments thereof. The present invention also provides compositions and pharmaceutical compositions comprising such antibodies, and method of making such antibodies. The present invention also provides methods of treatment and medical uses involving the antibodies.
    Type: Grant
    Filed: February 17, 2022
    Date of Patent: August 11, 2026
    Assignee: Adaptate Biotherapeutics Ltd.
    Inventors: Mihriban Tuna, Oxana Polyakova, Mark Uden, Robert Good, Joshua Freedman, Shefali Bhumbra, Natalie Mount, Aoife McGinley, Dan Foxler
  • ANTI-TCR DELTA VARIABLE 1 ANTIBODIES
    Publication number: 20230028110
    Abstract: The present invention provides high-affinity anti-TCR delta variable 1 (anti-V?1) antibodies and antibody fragments thereof. The present invention also provides compositions and pharmaceutical compositions comprising such antibodies, and method of making such antibodies. The present invention also provides methods of treatment and medical uses involving the antibodies.
    Type: Application
    Filed: February 17, 2022
    Publication date: January 26, 2023
    Applicant: Adaptate Biotherapeutics Ltd.
    Inventors: Mihriban TUNA, Oxana POLYAKOVA, Mark UDEN, Robert GOOD, Joshua FREEDMAN, Shefali BHUMBRA, Natalie MOUNT, Aoife MCGINLEY, Dan FOXLER